7,8-dihydrobenzo[e]pyrido[3,4-c]azocine-2,5(3H,6H)-dione derivatives useful as a factor XIa inhibitors | Patent Number 11897880

US 11897880 B2
Application Number17732724
Publication NumberUS 20220389005 A1
Pendency1 year, 9 months, 20 days
Filled DateApr 29, 2022
Priority DateApr 30, 2021
Publication DateDec 8, 2022
Expiration DateApr 29, 2041
Inventor/ApplicantsTianbao Lu
Guozhang Xu
Zhijie Liu
Micheal D. Gaul
ExaminesCHEN, PO-CHIH
Art Unit1621
Technology Center1600
Assignments
Janssen Pharmaceuticals Johnson & Johnson
Current
Janssen Pharmaceuticals Johnson & JohnsonJohnson & Johnson
Original
Law Firm
You must be logged in to view
Login
Attorneys
Subscription-Only
View Concierge Program
See the invalidated claims, subscribe to our Concierge Program.
View Concierge Program
Patent Prosecution report image

Empower your practice with Patexia Publication Prosecution IP Module.

Get access to our exclusive rankings and unlock powerful data.
Check our Latest ReportPurchase IP Module

Looking for a Publication Attorney?

Get in touch with our team or create your account to start exploring a network of over 120K attorneys.